Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming

Despite progress, our understanding of psychiatric and neurological illnesses remains poor, at least in part due to the inability to access neurons directly from patients. Currently, there are in vitro models available but significant work remains, including the search for a less invasive, inexpensi...

Full description

Bibliographic Details
Main Authors: Alfredo Bellon, Amelie Wegener, Adam R. Lescallette, Michael Valente, Seung-Kwon Yang, Robert Gardette, Julien Matricon, Faycal Mouaffak, Paula Watts, Lene Vimeux, Jong K. Yun, Yuka Imamura Kawasawa, Gary A. Clawson, Elisabeta Blandin, Boris Chaumette, Therese M. Jay, Marie-Odile Krebs, Vincent Feuillet, Anne Hosmalin
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2018.00323/full
_version_ 1828307657525559296
author Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Amelie Wegener
Amelie Wegener
Amelie Wegener
Amelie Wegener
Adam R. Lescallette
Michael Valente
Michael Valente
Michael Valente
Seung-Kwon Yang
Seung-Kwon Yang
Robert Gardette
Robert Gardette
Julien Matricon
Julien Matricon
Faycal Mouaffak
Faycal Mouaffak
Faycal Mouaffak
Paula Watts
Lene Vimeux
Lene Vimeux
Lene Vimeux
Jong K. Yun
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
Gary A. Clawson
Elisabeta Blandin
Elisabeta Blandin
Boris Chaumette
Boris Chaumette
Boris Chaumette
Boris Chaumette
Therese M. Jay
Therese M. Jay
Marie-Odile Krebs
Marie-Odile Krebs
Marie-Odile Krebs
Vincent Feuillet
Vincent Feuillet
Vincent Feuillet
Anne Hosmalin
Anne Hosmalin
Anne Hosmalin
author_facet Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Amelie Wegener
Amelie Wegener
Amelie Wegener
Amelie Wegener
Adam R. Lescallette
Michael Valente
Michael Valente
Michael Valente
Seung-Kwon Yang
Seung-Kwon Yang
Robert Gardette
Robert Gardette
Julien Matricon
Julien Matricon
Faycal Mouaffak
Faycal Mouaffak
Faycal Mouaffak
Paula Watts
Lene Vimeux
Lene Vimeux
Lene Vimeux
Jong K. Yun
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
Gary A. Clawson
Elisabeta Blandin
Elisabeta Blandin
Boris Chaumette
Boris Chaumette
Boris Chaumette
Boris Chaumette
Therese M. Jay
Therese M. Jay
Marie-Odile Krebs
Marie-Odile Krebs
Marie-Odile Krebs
Vincent Feuillet
Vincent Feuillet
Vincent Feuillet
Anne Hosmalin
Anne Hosmalin
Anne Hosmalin
author_sort Alfredo Bellon
collection DOAJ
description Despite progress, our understanding of psychiatric and neurological illnesses remains poor, at least in part due to the inability to access neurons directly from patients. Currently, there are in vitro models available but significant work remains, including the search for a less invasive, inexpensive and rapid method to obtain neuronal-like cells with the capacity to deliver reproducible results. Here, we present a new protocol to transdifferentiate human circulating monocytes into neuronal-like cells in 20 days and without the need for viral insertion or reprograming. We have thoroughly characterized these monocyte-derived-neuronal-like cells (MDNCs) through various approaches including immunofluorescence (IF), flow cytometry, qRT-PCR, single cell mRNA sequencing, electrophysiology and pharmacological techniques. These MDNCs resembled human neurons early in development, expressed a variety of neuroprogenitor and neuronal genes as well as several neuroprogenitor and neuronal proteins and also presented electrical activity. In addition, when these neuronal-like cells were exposed to either dopamine or colchicine, they responded similarly to neurons by retracting their neuronal arborizations. More importantly, MDNCs exhibited reproducible differentiation rates, arborizations and expression of dopamine 1 receptors (DR1) on separate sequential samples from the same individual. Differentiation efficiency measured by cell morphology was on average 11.9 ± 1.4% (mean, SEM, n = 38,819 cells from 15 donors). To provide context and help researchers decide which in vitro model of neuronal development is best suited to address their scientific question,we compared our results with those of other in vitro models currently available and exposed advantages and disadvantages of each paradigm.
first_indexed 2024-04-13T15:00:59Z
format Article
id doaj.art-38455e49d6fc4294acadec196640761d
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-04-13T15:00:59Z
publishDate 2018-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-38455e49d6fc4294acadec196640761d2022-12-22T02:42:18ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992018-09-011110.3389/fnmol.2018.00323382330Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without ReprogramingAlfredo Bellon0Alfredo Bellon1Alfredo Bellon2Alfredo Bellon3Alfredo Bellon4Alfredo Bellon5Alfredo Bellon6Amelie Wegener7Amelie Wegener8Amelie Wegener9Amelie Wegener10Adam R. Lescallette11Michael Valente12Michael Valente13Michael Valente14Seung-Kwon Yang15Seung-Kwon Yang16Robert Gardette17Robert Gardette18Julien Matricon19Julien Matricon20Faycal Mouaffak21Faycal Mouaffak22Faycal Mouaffak23Paula Watts24Lene Vimeux25Lene Vimeux26Lene Vimeux27Jong K. Yun28Yuka Imamura Kawasawa29Yuka Imamura Kawasawa30Gary A. Clawson31Elisabeta Blandin32Elisabeta Blandin33Boris Chaumette34Boris Chaumette35Boris Chaumette36Boris Chaumette37Therese M. Jay38Therese M. Jay39Marie-Odile Krebs40Marie-Odile Krebs41Marie-Odile Krebs42Vincent Feuillet43Vincent Feuillet44Vincent Feuillet45Anne Hosmalin46Anne Hosmalin47Anne Hosmalin48Penn State Hershey Medical Center, Department of Psychiatry, Hershey, PA, United StatesPenn State Hershey Medical Center, Department of Pharmacology, Hershey, PA, United StatesINSERM U1016, Institut Cochin, Paris, FranceCNRS UMR8104, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceCentre Hospitalier Sainte-Anne, Faculté de Médecine Paris Descartes, Service Hospitalo-Universitaire-S14, Paris, FranceINSERM U1016, Institut Cochin, Paris, FranceCNRS UMR8104, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FrancePenn State Hershey Medical Center, Department of Psychiatry, Hershey, PA, United StatesINSERM U1016, Institut Cochin, Paris, FranceCNRS UMR8104, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceCentre Hospitalier Sainte-Anne, Faculté de Médecine Paris Descartes, Service Hospitalo-Universitaire-S14, Paris, FranceSky Ridge Medical Center, Department of Internal Medicine, Lone Tree, CO, United StatesINSERM U1016, Institut Cochin, Paris, FranceCNRS UMR8104, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FrancePenn State Hershey Medical Center, Department of Pharmacology, Hershey, PA, United StatesPenn State Hershey Medical Center, Department of Pharmacology, Hershey, PA, United StatesPenn State Hershey Medical Center, Department of Biochemistry and Molecular Biology, Institute for Personalized Medicine, Hershey, PA, United States0Gittlen Cancer Research Laboratories, Department of Pathology, Penn State University College of Medicine, Hershey, PA, United StatesPenn State Hershey Medical Center, Department of Psychiatry, Hershey, PA, United States1Penn State Hershey Medical Center, Neural & Behavioral Sciences, Hershey, PA, United StatesUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceCentre Hospitalier Sainte-Anne, Faculté de Médecine Paris Descartes, Service Hospitalo-Universitaire-S14, Paris, France2Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, CanadaUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM UMR894, Center for Psychiatry and Neurosciences, Paris, FranceCentre Hospitalier Sainte-Anne, Faculté de Médecine Paris Descartes, Service Hospitalo-Universitaire-S14, Paris, FranceINSERM U1016, Institut Cochin, Paris, FranceCNRS UMR8104, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceINSERM U1016, Institut Cochin, Paris, FranceCNRS UMR8104, Paris, FranceUniversité Paris Descartes, Sorbonne Paris Cite, Paris, FranceDespite progress, our understanding of psychiatric and neurological illnesses remains poor, at least in part due to the inability to access neurons directly from patients. Currently, there are in vitro models available but significant work remains, including the search for a less invasive, inexpensive and rapid method to obtain neuronal-like cells with the capacity to deliver reproducible results. Here, we present a new protocol to transdifferentiate human circulating monocytes into neuronal-like cells in 20 days and without the need for viral insertion or reprograming. We have thoroughly characterized these monocyte-derived-neuronal-like cells (MDNCs) through various approaches including immunofluorescence (IF), flow cytometry, qRT-PCR, single cell mRNA sequencing, electrophysiology and pharmacological techniques. These MDNCs resembled human neurons early in development, expressed a variety of neuroprogenitor and neuronal genes as well as several neuroprogenitor and neuronal proteins and also presented electrical activity. In addition, when these neuronal-like cells were exposed to either dopamine or colchicine, they responded similarly to neurons by retracting their neuronal arborizations. More importantly, MDNCs exhibited reproducible differentiation rates, arborizations and expression of dopamine 1 receptors (DR1) on separate sequential samples from the same individual. Differentiation efficiency measured by cell morphology was on average 11.9 ± 1.4% (mean, SEM, n = 38,819 cells from 15 donors). To provide context and help researchers decide which in vitro model of neuronal development is best suited to address their scientific question,we compared our results with those of other in vitro models currently available and exposed advantages and disadvantages of each paradigm.https://www.frontiersin.org/article/10.3389/fnmol.2018.00323/fullstem cellsdopamineschizophrenianeuritein vitro modelGABA
spellingShingle Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Alfredo Bellon
Amelie Wegener
Amelie Wegener
Amelie Wegener
Amelie Wegener
Adam R. Lescallette
Michael Valente
Michael Valente
Michael Valente
Seung-Kwon Yang
Seung-Kwon Yang
Robert Gardette
Robert Gardette
Julien Matricon
Julien Matricon
Faycal Mouaffak
Faycal Mouaffak
Faycal Mouaffak
Paula Watts
Lene Vimeux
Lene Vimeux
Lene Vimeux
Jong K. Yun
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
Gary A. Clawson
Elisabeta Blandin
Elisabeta Blandin
Boris Chaumette
Boris Chaumette
Boris Chaumette
Boris Chaumette
Therese M. Jay
Therese M. Jay
Marie-Odile Krebs
Marie-Odile Krebs
Marie-Odile Krebs
Vincent Feuillet
Vincent Feuillet
Vincent Feuillet
Anne Hosmalin
Anne Hosmalin
Anne Hosmalin
Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming
Frontiers in Molecular Neuroscience
stem cells
dopamine
schizophrenia
neurite
in vitro model
GABA
title Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming
title_full Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming
title_fullStr Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming
title_full_unstemmed Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming
title_short Transdifferentiation of Human Circulating Monocytes Into Neuronal-Like Cells in 20 Days and Without Reprograming
title_sort transdifferentiation of human circulating monocytes into neuronal like cells in 20 days and without reprograming
topic stem cells
dopamine
schizophrenia
neurite
in vitro model
GABA
url https://www.frontiersin.org/article/10.3389/fnmol.2018.00323/full
work_keys_str_mv AT alfredobellon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT alfredobellon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT alfredobellon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT alfredobellon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT alfredobellon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT alfredobellon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT alfredobellon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT ameliewegener transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT ameliewegener transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT ameliewegener transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT ameliewegener transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT adamrlescallette transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT michaelvalente transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT michaelvalente transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT michaelvalente transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT seungkwonyang transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT seungkwonyang transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT robertgardette transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT robertgardette transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT julienmatricon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT julienmatricon transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT faycalmouaffak transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT faycalmouaffak transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT faycalmouaffak transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT paulawatts transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT lenevimeux transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT lenevimeux transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT lenevimeux transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT jongkyun transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT yukaimamurakawasawa transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT yukaimamurakawasawa transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT garyaclawson transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT elisabetablandin transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT elisabetablandin transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT borischaumette transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT borischaumette transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT borischaumette transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT borischaumette transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT theresemjay transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT theresemjay transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT marieodilekrebs transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT marieodilekrebs transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT marieodilekrebs transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT vincentfeuillet transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT vincentfeuillet transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT vincentfeuillet transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT annehosmalin transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT annehosmalin transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming
AT annehosmalin transdifferentiationofhumancirculatingmonocytesintoneuronallikecellsin20daysandwithoutreprograming